IP Verse

Mesalazine Tablet Having Improved Dissolution - EP2611429

PATENT ANALYSIS

Patent Details

Grant Date
Feb 21, 2018
Company
DISPHAR INTERNATIONAL B.V.
Oppositions

TILLOTTS PHARMA AG

More patents of Disphar International B.V.

EP2611429

Want to monitor this patent?

Feel free to send us a message here and we will get back to you